Treatment with gluten free diet in coeliac disease is associated with a rapid improvement in small bowel histology,l nutritional deficiency,2 and symptomatic well being, but the effect of gluten free diet on the reduced bone mineral density (osteopenia) often found at diagnosis3-4 in coeliac disease remains to be determined. Osteopenia present at the time of diagnosis of coeliac disease may be due to osteomalacia, osteoporosis or secondary hyperparathyroidism,5A and can be detected by noninvasive bone densitometry,3A although this technique cannot be used to identify the underlying pathology.
The measurement of bone mineral density (BMD) provides important objective information in the assessment of an individual's fracture risk, as BMD at a given skeletal site is an important determinant of fracture risk at that site,7-8 with age and predilection to falls representing additional independent factors. Thus, patients with a Z score (number of standard deviations by which patients BMD differs from age and sex matched normal mean BMD) of -1 have a 2*4-fold increase in lifetime fracture risk, and patients with Z score of -2 have a fivefold increase.9
In this study we have performed an initial BMD measurement on adults with coeliac disease, within 12 months of diagnosis and commencement of treatment with a gluten free diet, and repeated the measurement after one year. In addition, we have performed iliac crest bone biopsy to elucidate the underlying bone pathology in patients with skeletal symptoms at the time of diagnosis of coeliac disease.
Methods
Twenty one patients (14 females, seven males, average age 49-7 years, range 31.0 to 66.1) with newly diagnosed coeliac disease were studied. The Table shows the principal symptom leading to investigation and diagnosis of coeliac disease in each patient. The diagnosis of coeliac disease was based on clinical presentation and small intestinal biopsy in all patients prior to treatment with gluten free diet.1 All patients had a clinical and haematological response to gluten free diet. Twelve patients showed significant improvement on repeat small bowel biopsy. Two patients had persistent subtotal villous atrophy on repeat biopsy (after six and 12 months). Six patients did not have a repeat small bowel biopsy.
Three patients had significant skeletal symptoms at the time of first presentation, two of which were initially referred by their general practitioner to a rheumatology outpatients department. The first of these three patients was a 66 year old woman who presented with bone pain, muscle weakness, and a clinical, biochemical and histological picture of osteomalacia complicated by secondary hyperparathyroidism (Fig 1) children with coeliac disease given a gluten free nts with the lowest BMD have the greatest diet, in whom an increase in BMD would be itage change in BMD over the 12 month interval, expected with growth. A previous study of the ee patients with osteomalacia are represented by open effect of gluten free diet on BM in adults with newly diagnosed coeliac disease4 failed to show any gain in BMD during the first year bar spine (mean -07%/o, 95°/O CI: -1.9% of dietary treatment, however BMD was -0.5%) or at femoral neck (mean +0.9%, measured using the older and less precise tech-CI: -0.8% to +2.7%). In patients there nique of single photon absorptiometry, and a strong correlation between the rate of this technique may have been too insensitive to ige in BMD (0/o/year) at lumbar spine and detect the relatively small change in BMD. ate of change at the femoral neck (r=0-76, The gain of BMD at both lumbar spine and 001).
femoral neck was apparent in almost all of the Ltients with osteomalacia had among the patients in our study, ranging from the modest test gains in BMD at both lumbar spine increases in most patients, to the dramatic femoral neck over the 12 months. Rates of increases seen in patients with osteomalacia. Lge of BMD at both lumbar spine and The lower bone density in patients than )ral neck were negatively correlated with controls at the beginning of the study and the bar spine Z score (r= 0.5 1, p<0 05 at both gains of BMD at both lumbar spine and bar spine and femoral neck, Fig 5) , the femoral neck were still significant even if the t severely osteopaenic patients having the analysis excluded the three patients who had t rapid gain in BMD, and patients with osteomalacia demonstrated at bone biopsy. nal initial BMD demonstrating only small Patients with osteomalacia were particularly Lases in BMD. There was a greater weight susceptible to osteopaenia at the lumbar spine over the 12 months in patients (+4.5%) and this may be because of the high proportion CI: +2.2 to +6.3%), than controls of trabecular bone at this site, which therefore *10%, 95% CI: +0 1 to +2-3%). In patients has a higher surface to volume ratio and therewas no correlation between change in fore greater metabolic activity than the femoral ,ht and change in BMD.
neck, which has a greater proportion of cortical s a result of these increases over 12 bone. 14 iths, the lumbar spine BMD of patients, At any given point in time there is a essed as a percentage of the lumbar spine reversible mineral deficit15 of approximately D of their paired control, increased from 1-5% of total bone mineral, equivalent to the % at the beginning of the study, to 86 1/% fraction of the normal skeleton undergoing 12 p<.O O1 at both sites), whereas the patients increased bone turnover. In coeliac disease se first BMD measurement was six to 12 increased bone turnover would possibly be iths after commencing gluten free diet driven by the secondary hyperparathyroidism ved no significant increase at either site due to a negative calcium balance.6 Given this 0 10).
proposed mechanism it is not likely that bone density would increase for much longer than the duration of this study, and it is likely that the maximal improvement would be apparent by two years after commencing a gluten free diet. This result is supported by our finding of a significant gain in BMD only in the subgroup of patients on gluten free diet for less than six months at the start of the study. In the patients with osteomalacia the mechanism of increase in BMD is the re-mineralisation of the large volume of unmineralised osteoid matrix, as a consequence of improved calcium and vitamin D status.6
In our study, despite the significant gain in BMD on treatment with gluten free diet for 12 months, there was still residual osteopenia; patients with coeliac disease still had lumbar spine and femoral neck BMD only 86% and 87% respectively, of that of age and sex matched normal controls. The optimal timing for BMD measurements in coeliac disease remains to be established, but an initial measurement at the time of diagnosis, followed by repeat measurement 12 months later will detect patients with persistent osteopenia. All patients with newly diagnosed coeliac disease need careful dietary advice, to emphasise compliance with a gluten free diet and an adequate calcium and vitamin D intake, if necessary with calcium supplementation. There is evidence that calcium intake is reduced in some subjects with coeliac disease,1' and that calcium malabsorption persists despite compliance with a gluten free diet. [16] [17] In patients who have persistent osteopenia further measures may need to be taken. In women who are approaching the menopause hormone replacement therapy should be considered, and with patients with established osteoporotic fractures bisphosphonates may be offered. Patients with coeliac disease should be advised of the often silent effects of untreated coeliac disease on the skeleton, and of the importance of adhering to a gluten free diet, even if there are no gastrointestinal or skeletal symptoms.
